The Impact of Medication Non-adherence on Adverse Outcomes: Evidence from Schizophrenia Patients via Survival Analysis
Shahriar Noroozizadeh, Pim Welle, Jeremy C. Weiss, George H. Chen

TL;DR
This study uses survival analysis and causal inference methods to quantify how medication non-adherence accelerates adverse outcomes in schizophrenia patients, emphasizing the clinical importance of adherence.
Contribution
It extends causal inference techniques to survival models in psychiatric medication adherence, providing new insights into timing of adverse events.
Findings
Non-adherence advances adverse outcomes by 1-4 months.
Risk scores effectively adjust for confounders.
Consistent effects across medication types and formulations.
Abstract
This study quantifies the association between non-adherence to antipsychotic medications and adverse outcomes in individuals with schizophrenia. We frame the problem using survival analysis, focusing on the time to the earliest of several adverse events (early death, involuntary hospitalization, jail booking). We extend standard causal inference methods (T-learner, S-learner, nearest neighbor matching) to utilize various survival models to estimate individual and average treatment effects, where treatment corresponds to medication non-adherence. Analyses are repeated using different amounts of longitudinal information (3, 6, 9, and 12 months). Using data from Allegheny County in western Pennsylvania, we find strong evidence that non-adherence advances adverse outcomes by approximately 1 to 4 months. Ablation studies confirm that county-provided risk scores adjust for key confounders, as…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHealth Systems, Economic Evaluations, Quality of Life
